Publicaciones en las que colabora con Ricardo Blanco Alonso (11)

2024

  1. Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patients

    Seminars in Arthritis and Rheumatism, Vol. 68

2022

  1. Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure

    Seminars in Arthritis and Rheumatism, Vol. 52

2020

  1. Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).

    Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 4, pp. 657-662

2016

  1. Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry

    Rheumatology (United Kingdom), Vol. 55, Núm. 7, pp. 1243-1250

2011

  1. Relapses and recurrences in giant cell arteritis: A population-based study of patients with biopsy-proven disease from Northwestern Spain

    Medicine, Vol. 90, Núm. 3, pp. 186-193

  2. Role of the rs6822844 gene polymorphism at the IL2-IL21 region in biopsy-proven giant cell arteritis

    Clinical and Experimental Rheumatology, Vol. 29, Núm. 1 SUPPL. 64

  3. Systemic lupus erythematosus in Northwestern Spain: A 20-year epidemiologic study

    Medicine, Vol. 90, Núm. 5, pp. 350-358

2010

  1. Influence of CD40 rs1883832 polymorphism in susceptibility to and clinical manifestations of biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 37, Núm. 10, pp. 2076-2080

  2. Influence of IL2RA rs2104286 polymorphism in the risk of biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 37, Núm. 11, pp. 2331-2333

2009

  1. Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis

    Medicine, Vol. 88, Núm. 4, pp. 227-235

  2. The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease

    Medicine, Vol. 88, Núm. 6, pp. 358-365